[{"id":"8692edc5-36b9-41d3-83ee-d4803fca127c","acronym":"","url":"https://clinicaltrials.gov/study/NCT05835687","created_at":"2023-04-28T15:04:55.022Z","updated_at":"2024-07-02T16:35:14.889Z","phase":"Phase 1","brief_title":"Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors","source_id_and_acronym":"NCT05835687","lead_sponsor":"St. Jude Children's Research Hospital","biomarkers":" CD276","pipe":"","alterations":" ","tags":["CD276"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e B7-H3 CAR-T"],"overall_status":"Recruiting","enrollment":" Enrollment 36","initiation":"Initiation: 04/27/2023","start_date":" 04/27/2023","primary_txt":" Primary completion: 03/01/2028","primary_completion_date":" 03/01/2028","study_txt":" Completion: 03/01/2028","study_completion_date":" 03/01/2028","last_update_posted":"2024-03-13"},{"id":"cc4fb18b-f792-4ae9-84d7-f106ddc4db2d","acronym":"","url":"https://clinicaltrials.gov/study/NCT04897321","created_at":"2021-05-21T11:52:50.695Z","updated_at":"2024-07-02T16:35:40.645Z","phase":"Phase 1","brief_title":"B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)","source_id_and_acronym":"NCT04897321","lead_sponsor":"St. Jude Children's Research Hospital","biomarkers":" CD276","pipe":" | ","alterations":" CD276 expression","tags":["CD276"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD276 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • mesna • B7-H3 CAR-T • cyclophosphamide intravenous"],"overall_status":"Recruiting","enrollment":" Enrollment 32","initiation":"Initiation: 07/06/2022","start_date":" 07/06/2022","primary_txt":" Primary completion: 03/01/2026","primary_completion_date":" 03/01/2026","study_txt":" Completion: 03/01/2027","study_completion_date":" 03/01/2027","last_update_posted":"2023-08-08"}]